WO2012064146A3 - Gkn 1을 함유하는 항암용 조성물 - Google Patents
Gkn 1을 함유하는 항암용 조성물 Download PDFInfo
- Publication number
- WO2012064146A3 WO2012064146A3 PCT/KR2011/008605 KR2011008605W WO2012064146A3 WO 2012064146 A3 WO2012064146 A3 WO 2012064146A3 KR 2011008605 W KR2011008605 W KR 2011008605W WO 2012064146 A3 WO2012064146 A3 WO 2012064146A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gkn
- composition containing
- anticancer
- anticancer composition
- outstanding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
본 발명은 GKN 1을 유효성분으로 함유하는 항암용 조성물에 관한 것으로서, 보다 구체적으로는 항암 활성이 우수한 GKN 1 유전자를 포함하는 발현벡터 또는 GKN 1 단백질을 유효성분으로 함유하는 항암용 조성물에 관한 것이다. 본 발명에 따른 GKN 1은 암세포의 발생을 억제하는 활성이 우수할 뿐만 아니라, 과발현시 암 세포의 전이를 억제하는 활성도 우수한 특징이 있으므로 항암 치료용 조성물로 유용하게 사용될 수 있는 효과가 있다.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011800546195A CN103209702A (zh) | 2010-11-12 | 2011-11-11 | 含有gkn1的抗癌用组合物 |
EP11839104.4A EP2641610A4 (en) | 2010-11-12 | 2011-11-11 | ANTICANCER COMPOSITION CONTAINING GKN 1 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2010-0112610 | 2010-11-12 | ||
KR1020100112610A KR101215069B1 (ko) | 2010-11-12 | 2010-11-12 | Gkn 1을 함유하는 항암용 조성물 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2012064146A2 WO2012064146A2 (ko) | 2012-05-18 |
WO2012064146A9 WO2012064146A9 (ko) | 2012-08-02 |
WO2012064146A3 true WO2012064146A3 (ko) | 2012-08-23 |
Family
ID=46051452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/008605 WO2012064146A2 (ko) | 2010-11-12 | 2011-11-11 | Gkn 1을 함유하는 항암용 조성물 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2641610A4 (ko) |
KR (1) | KR101215069B1 (ko) |
CN (1) | CN103209702A (ko) |
WO (1) | WO2012064146A2 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101394828B1 (ko) * | 2012-08-07 | 2014-05-13 | 가톨릭대학교 산학협력단 | 항암활성을 갖는 gkn1의 아미노 말단 조절 모티프의 용도 |
KR101385357B1 (ko) * | 2012-08-07 | 2014-04-14 | 가톨릭대학교 산학협력단 | 항암 활성을 갖는 GKN1 brichos 도메인의 용도 |
EP3284476B1 (en) | 2012-12-19 | 2019-09-25 | Lumen Bio LLC | Uses of a gastrokine protein |
KR102256159B1 (ko) | 2014-11-06 | 2021-05-26 | 가톨릭대학교 산학협력단 | Gkn1을 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 조성물 |
KR101803636B1 (ko) | 2015-03-31 | 2017-12-01 | 가톨릭대학교 산학협력단 | Ssu72를 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 조성물 |
WO2019035602A2 (ko) * | 2017-08-16 | 2019-02-21 | 가톨릭대학교 산학협력단 | 혈액 내 gkn1 단백을 이용하는 위암 진단 |
KR101988120B1 (ko) | 2017-08-21 | 2019-09-27 | 가톨릭대학교 산학협력단 | 혈액 내 gastrokine 1 단백을 이용하는 위암 진단 |
KR101988118B1 (ko) * | 2017-08-16 | 2019-06-11 | 가톨릭대학교 산학협력단 | Gkn1 단백을 포함하는 항암 조성물 |
KR102430127B1 (ko) | 2019-10-24 | 2022-08-11 | 가톨릭대학교 산학협력단 | 인테그린 알파 6 와 알파 x를 포함하는 암 예방 또는 치료용 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006037521A1 (de) * | 2004-10-01 | 2006-04-13 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung von gastrokine 1 (gkn1) als biomarker für entzündungen und infektionen |
US20100113356A1 (en) * | 2001-03-29 | 2010-05-06 | The University Of Chicago | Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037187A1 (fr) * | 1997-02-21 | 1998-08-27 | Takara Shuzo Co., Ltd. | Genes associes au cancer |
CN101735315A (zh) * | 2008-11-21 | 2010-06-16 | 中国科学院北京基因组研究所 | Amp-18抗原多肽及其在制备治疗肿瘤药物中的应用 |
CN101665831A (zh) * | 2009-07-14 | 2010-03-10 | 东华大学 | Tnfsf13作为光敏剂药靶的肿瘤光动力疗法光敏剂的筛选方法 |
CN102827266A (zh) * | 2011-06-14 | 2012-12-19 | 北京华大蛋白质研发中心有限公司 | 一种层粘连蛋白受体的配体胃窦粘膜蛋白-18在肿瘤治疗中的应用 |
-
2010
- 2010-11-12 KR KR1020100112610A patent/KR101215069B1/ko not_active IP Right Cessation
-
2011
- 2011-11-11 EP EP11839104.4A patent/EP2641610A4/en not_active Withdrawn
- 2011-11-11 CN CN2011800546195A patent/CN103209702A/zh active Pending
- 2011-11-11 WO PCT/KR2011/008605 patent/WO2012064146A2/ko active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100113356A1 (en) * | 2001-03-29 | 2010-05-06 | The University Of Chicago | Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
WO2006037521A1 (de) * | 2004-10-01 | 2006-04-13 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung von gastrokine 1 (gkn1) als biomarker für entzündungen und infektionen |
Non-Patent Citations (3)
Title |
---|
GERARDO NARDONE ET AL.: "Molecular expression of gastrokine 1 in normal mucosa and in Helicobacter pylori-related preneoplastic and neoplastic gastic lesions", CANCER BIOLOGY & THERAPY, vol. 7, no. 12, 2008, pages 1890 - 1895, XP055116241 * |
KARIN A. OIEN ET AL.: "Gsatrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation", JOURNAL OF PATHOLOGY, vol. 203, 2004, pages 789 - 797, XP055116238 * |
See also references of EP2641610A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP2641610A4 (en) | 2014-12-31 |
CN103209702A (zh) | 2013-07-17 |
EP2641610A2 (en) | 2013-09-25 |
WO2012064146A9 (ko) | 2012-08-02 |
KR101215069B1 (ko) | 2012-12-24 |
WO2012064146A2 (ko) | 2012-05-18 |
KR20120051258A (ko) | 2012-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012064146A3 (ko) | Gkn 1을 함유하는 항암용 조성물 | |
WO2011056021A3 (ko) | 벤조헤테로사이클 유도체의 암 예방 및 치료 또는 암 전이 억제를 위한 용도 | |
WO2010041913A3 (ko) | Grs 단백질 또는 이의 단편의 신규한 용도 | |
EP3736294A3 (en) | Cd73 blockade | |
NZ602557A (en) | Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | |
NZ595938A (en) | Tumor suppression using placental stem cells | |
IN2012DN03824A (ko) | ||
EP4241854A3 (en) | Lysosomal storage disease enzyme | |
WO2008085221A3 (en) | Therapeutic use of cd31 expressing cells | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
WO2008125846A3 (en) | Genetic suppression and replacement | |
WO2013023084A3 (en) | Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells | |
WO2012104007A3 (de) | 7-azaindolderivate | |
WO2014026110A3 (en) | Compounds for improved viral transduction | |
WO2011129936A3 (en) | Compositions and methods for the prevention and treatment of cancer | |
WO2009095261A3 (en) | Vaccine compositions | |
UA112549C2 (uk) | Частинки на основі поліакрилату, що містять активну сполуку | |
WO2012006169A3 (en) | Compositions and methods for enhancement of nucleic acid delivery | |
WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
WO2012169822A3 (ko) | 암세포 증식 억제와 혈관신생 억제를 위한 융합 단백질 및 이를 포함한 항암 조성물 | |
WO2010140862A3 (ko) | 단일 또는 멀티 표적 유전자를 억제하는 멀티-시스트로닉 shRNA 발현 카세트 | |
WO2010086838A3 (en) | Non-ad5 adenoviral vectors and methods and uses related thereto | |
MX2010008942A (es) | Paramyxovirus eficaz como antitumoral. | |
WO2014028939A3 (en) | Targeting phosphofructokinase and its glycosylation form for cancer | |
PH12015501131A1 (en) | Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11839104 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011839104 Country of ref document: EP |